These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1730479)

  • 1. Protective local and systemic antibody responses of swine exposed to an aerosol of Actinobacillus pleuropneumoniae serotype 1.
    Bossé JT; Johnson RP; Nemec M; Rosendal S
    Infect Immun; 1992 Feb; 60(2):479-84. PubMed ID: 1730479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge.
    Hensel A; Stockhofe-Zurwieden N; Petzoldt K; Lubitz W
    Infect Immun; 1995 Aug; 63(8):3048-53. PubMed ID: 7622229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol exposure of pigs to viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces antibodies in bronchoalveolar lining fluids and serum, and protects against homologous challenge.
    Hensel A; Stockhofe-Zurwieden N; Ganter M; Petzoldt K
    Vet Microbiol; 1995 Nov; 47(1-2):27-41. PubMed ID: 8604553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
    Hensel A; Huter V; Katinger A; Raza P; Strnistschie C; Roesler U; Brand E; Lubitz W
    Vaccine; 2000 Jul; 18(26):2945-55. PubMed ID: 10825595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2.
    Loftager MK; Eriksen L; Aasted B; Nielsen R
    Res Vet Sci; 1993 Nov; 55(3):281-6. PubMed ID: 8284489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against Actinobacillus pleuropneumoniae serotype 2 in mucosal secretions and sera of infected pigs as demonstrated by an enzyme-linked immunosorbent assay.
    Loftager MK; Eriksen L; Nielsen R
    Res Vet Sci; 1993 Jan; 54(1):57-62. PubMed ID: 8434149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs.
    Hensel A; Pabst R; Bunka S; Petzoldt K
    Clin Exp Immunol; 1994 Apr; 96(1):91-7. PubMed ID: 8149673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae.
    Byrd W; Harmon BG; Kadis S
    Vet Immunol Immunopathol; 1992 Nov; 34(3-4):307-24. PubMed ID: 1455686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral antibody response and protective immunity in swine following immunization with the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae.
    Devenish J; Rosendal S; Bossé JT
    Infect Immun; 1990 Dec; 58(12):3829-32. PubMed ID: 2254012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody- and cell-mediated immune responses of Actinobacillus pleuropneumoniae-infected and bacterin-vaccinated pigs.
    Furesz SE; Mallard BA; Bossé JT; Rosendal S; Wilkie BN; MacInnes JI
    Infect Immun; 1997 Feb; 65(2):358-65. PubMed ID: 9009283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect enzyme-linked immunosorbent assay for detection of antibody to a 110,000-molecular-weight hemolysin of Actinobacillus pleuropneumoniae.
    Ma JN; Inzana TJ
    J Clin Microbiol; 1990 Jun; 28(6):1356-61. PubMed ID: 2380363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses.
    Katinger A; Lubitz W; Szostak MP; Stadler M; Klein R; Indra A; Huter V; Hensel A
    J Biotechnol; 1999 Aug; 73(2-3):251-60. PubMed ID: 10486934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia.
    Haga Y; Ogino S; Ohashi S; Ajito T; Hashimoto K; Sawada T
    J Vet Med Sci; 1997 Feb; 59(2):115-20. PubMed ID: 9070983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and local antibody responses after experimental infection with Actinobacillus pleuropneumoniae in piglets with passive or active immunity.
    Krejci J; Nechvatalova K; Kudlackova H; Faldyna M; Kucerova Z; Toman M
    J Vet Med B Infect Dis Vet Public Health; 2005 May; 52(4):190-6. PubMed ID: 16000115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an attenuated strain of Actinobacillus pleuropneumoniae, serotype 1.
    Rosendal S; MacInnes JI
    Am J Vet Res; 1990 May; 51(5):711-7. PubMed ID: 2337267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.
    Shin SJ; Bae JL; Cho YW; Lee DY; Kim DH; Yang MS; Jang YS; Yoo HS
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):155-64. PubMed ID: 15681145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants.
    Byrd W; Kadis S
    Infect Immun; 1992 Aug; 60(8):3042-51. PubMed ID: 1639471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
    Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.
    Seo KW; Kim SH; Park J; Son Y; Yoo HS; Lee KY; Jang YS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):102-12. PubMed ID: 23200821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum responses in swine after vaccination and challenge exposure with Actinobacillus pleuropneumoniae serotype 1.
    Stine DL; Fedorka-Cray PJ; Huether MJ; Gentry MJ; Anderson GA
    Am J Vet Res; 1994 Sep; 55(9):1238-43. PubMed ID: 7802390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.